IL2 and Huntington disease: Regarding the Th1-type cytokines, including IFN-γ, IL-2, and IL-12, the HD patients in the breakthrough infection group had higher IFN-γ levels than those in the booster immunization group (p = 0.039), but there was no significant difference between the control and HD patients in either of the groups.